Biological oils and production and uses thereof

Details for Australian Patent Application No. 2008300002 (hide)

Owner Martek Biosciences Corporation

Inventors Martin, David Christian; Behrens, Paul Warren; Hansen, Jon Milton; Lippmeier, James Casey; Pfeifer III, Joseph W.; Apt, Kirk E.; Barclay, William Robert

Agent Davies Collison Cave

Pub. Number AU-A-2008300002

PCT Pub. Number WO2009/035551

Priority 60/960,037 12.09.07 US

Filing date 8 September 2008

Wipo publication date 19 March 2009

International Classifications

C12P 7/64 (2006.01) Preparation of oxygen-containing organic compounds - Fats

C12P 1/04 (2006.01) Preparation of compounds or compositions, not provided for in groups , by using micro-organisms or enzymes - by using bacteria

Event Publications

29 April 2010 PCT application entered the National Phase

  PCT publication WO2009/035551 Priority application(s): WO2009/035551

20 September 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

25 October 2012 Section 223 Application Allowed

  Martek Biosciences Corporation The time in which to request examination has been extended to 14 Oct 2012 . Address for service in Australia - Phillips Ormonde Fitzpatrick 367 Collins Street Melbourne VIC 3000

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008300011-Methods of using genetic markers and related epistatic interactions

2008299993-Guanidine-containing compounds useful as muscarinic receptor antagonists